Sentence examples for varying the binding from inspiring English sources

Drug release from tissue scaffolds is commonly controlled by using coatings and carriers, as well as by varying the binding affinity of molecules being released.

The effect of the ratio of binding sites to drug, the effect of varying the binding kinetics and the rate of enzymatic matrix degradation on the rate of drug release was examined.

Following the same arguments as for single species transport, varying the binding strength from infinitely high values to infinitely low values (corresponding to completely repulsive interaction), lets the flow vary from zero through some maximum value to zero again.

The AUC scores are measured by area under ROC curves derived from predictions of gold standard sequences being bound by SRSF1 proteins varying the binding affinity threshold.

By varying the binding parameters on the surface, allocation of different amounts of photoinitiator to sites containing a constant amount of biotin target is achievable.

To examine the role of drug dose and antibody target binding affinity in determining drug efficacy, we ran multiple simulations while systematically varying the dose and binding affinities of the antibodies.

We also studied the system by varying the rate of binding of miRNA to mRNA (c3), which was increased keeping the rate of production of the miRNA (c1) and rate of degradation of RISC (c4) fixed at appropriate level.

For each topology, we study the dependence of noise characteristics on the kinetic rates by varying the dimer lifetime, binding affinity, and the individual association/dissociation rates (see Table and Fig. 1).

To further investigate the efficacy of our approach in analyzing repositioning time courses, we conducted an additional set of simulations in which we generated different fractions of bound ISWI by varying the probability of binding in the simulation.

Use of a single autoinhibitory PDZ pair resulted in a noncooperative dose-response to free SH3, while varying the numbers and binding affinities of the decoy domains led to a variety of dose-responses to SH3, implementing horizontal scaling and steepness tuning.

The rate of release was tunable by varying either the binding strength of the SH3-protein/SH3-peptide pair or the SH3-peptide to SH3-protein ratio.